Brief: Inovio Pharmaceuticals Q1 Operating Expenses USD 25.1 Million
13/05/2025 21:11
May 13 (Reuters) - Inovio Pharmaceuticals Inc INO.O: INOVIO PHARMACEUTICALS Q1 OPERATING EXPENSES USD 25.1 MILLION INOVIO PHARMACEUTICALS Q1 EPS USD -0.51 INOVIO PHARMACEUTICALS Q1 NET INCOME USD -19.7 MILLION Source text: ID:nPn2hfWcga Further company coverage: INO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inovio Pharmaceuticals
See all newsBrief: Inovio Announces Favorable Judgment In Litigation With Vgxi, Inc. And Geneone Life Science
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Inovio Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Inovio Q2 net loss narrows on warrant gain, lower costs
Brief: Inovio Pharmaceuticals Q2 Operating Expenses USD 18.6 Million